Skip to main content
NeuroThera Labs Inc. logo

NeuroThera Labs Inc. — Investor Relations & Filings

Ticker · NTLX ISIN · CA64136J1012 LEI · 529900GPL3C0DVADMS32 TSXV Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2021-06-09 Regulatory Filings
Country CA Canada
Listing TSXV NTLX

About NeuroThera Labs Inc.

https://www.neurothera.com/

NeuroThera Labs Inc. is a clinical-stage company specializing in the development of therapeutics and advanced technologies for central nervous system (CNS) disorders and brain health. The company operates through two primary development streams. First, it is a leader in photobiomodulation (PBM) technology, developing drug-free, non-invasive devices for neurotherapy, targeting conditions such as Major Depressive Disorder (MDD), Alzheimer’s Disease, and Traumatic Brain Injury (TBI). Second, NeuroThera maintains a pharmaceutical pipeline focused on novel drug candidates, including programs based on THC and proprietary opioid/non-opioid compounds designed to enhance pain relief and treat CNS disorders. This dual approach leverages both advanced medical devices and clinical-stage drug candidates to address prevalent neurological conditions.

Recent filings

Filing Released Lang Actions
Final prospectus – English.pdf
Regulatory Filings
2021-06-09 English
Escrow agreement.pdf
Regulatory Filings
2021-06-09 English
Underwriting or agency agreement.pdf
Regulatory Filings
2021-06-09 English
Consent letter(s) of issuer's legal counsel.pdf
Regulatory Filings Classification · 95% confidence The document is a legal consent letter from Buttonwood Law Corporation regarding the final prospectus of Miza III Ventures Inc. It references the prospectus and confirms no misrepresentations in the legal opinions provided. The document is short (1307 characters) and does not contain financial data or detailed report content. It is related to a prospectus, which is a capital raising document, but this letter itself is a legal consent related to that prospectus, not the prospectus or a financing update itself. Given the nature and length, it fits best as a Regulatory Filing (RNS) since it is a legal attestation related to a regulatory filing but not the filing itself.
2021-06-09 English
Decision Document (Preliminary).pdf
Regulatory Filings Classification · 100% confidence The document is a receipt issued by the British Columbia Securities Commission for a Preliminary CPC Prospectus filed by Miza III Ventures Inc. It is a regulatory acknowledgment of the filing of a prospectus, not the prospectus itself or a financial report. The document is short (895 characters) and serves as an official regulatory filing receipt. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance document acknowledging the filing, not a report or announcement of financial results or corporate actions.
2021-04-15 English
Preliminary prospectus – English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled 'Preliminary Prospectus' and relates to an Initial Public Offering (IPO) of common shares by Miza III Ventures Inc. It contains detailed information about the offering price, number of shares, use of proceeds, agent compensation, stock options, listing application, and risk factors. The document is a formal offering prospectus filed with securities regulatory authorities and the TSX Venture Exchange. It is not an announcement or a brief summary but a comprehensive legal and financial disclosure document intended for potential investors. This type of document is classified as a Capital/Financing Update (CAP) because it pertains to the company's fundraising activities and capital structure changes through a public offering of shares.
2021-04-15 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.